checkAd

    DGAP-News  454  0 Kommentare STRATEC reports on first three months of 2013 - Seite 3


    given our current business performance, we expect to generate sales growth
    accompanied by increasing profitability in 2013. We plan to issue an update
    of the company forecast for the current financial year and subsequent years
    in the course of the first half of 2013.

    Further details can be found in our Interim Report as of March 31, 2013
    published at www.stratec.com > Investor Relations > IR News > Financial
    Reports.


    About STRATEC
    STRATEC Biomedical AG (www.stratec.com) designs and manufactures fully
    automated analyzer systems for its partners in the fields of clinical
    diagnostics and biotechnology. These partners market such systems, in
    general together with their own reagents, as system solutions to
    laboratories, blood banks and research institutes around the world. The
    company develops its products on the basis of its own patented
    technologies.

    Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard
    segment of the Frankfurt Stock Exchange and are listed in the TecDAX select
    index of the German Stock Exchange.


    Further information can be obtained from:
    STRATEC Biomedical AG
    André Loy, Investor Relations
    Gewerbestr. 37, 75217 Birkenfeld
    Germany
    Tel: +49 7082 7916-190
    Fax: +49 7082 7916-999
    ir@stratec.com
    www.stratec.com


    End of Corporate News

    ---------------------------------------------------------------------

    07.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
    company of EquityStory AG.
    The issuer is solely responsible for the content of this announcement.

    DGAP's Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Media archive at www.dgap-medientreff.de and www.dgap.de

    ---------------------------------------------------------------------


    Language: English
    Company: STRATEC Biomedical AG
    Gewerbestr. 37
    75217 Birkenfeld
    Germany
    Phone: +49 (0)7082 7916 0
    Fax: +49 (0)7082 7916 999
    E-mail: info@stratec.com
    Internet: www.stratec.com
    ISIN: DE0007289001
    WKN: 728900
    Indices: TecDAX
    Listed: Regulierter Markt in Frankfurt (Prime Standard);
    Freiverkehr in Berlin, Düsseldorf, München, Stuttgart


    End of News DGAP News-Service
    ---------------------------------------------------------------------
    209894 07.05.2013
    Seite 3 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News STRATEC reports on first three months of 2013 - Seite 3 DGAP-News: STRATEC Biomedical AG / Key word(s): Quarter Results/Interim Report STRATEC reports on first three months of 2013 07.05.2013 / 07:27 --------------------------------------------------------------------- STRATEC reports on first three …

    Schreibe Deinen Kommentar

    Disclaimer